CVS is reportedly conducting a strategic review and weighing options for separating some of the company’s businesses.
CVS risks losing customers and revenue if it splits up its vertically integrated business segments, which includes health ...
It's not a good time to be in the pharmacy business. Online competition, rampant shoplifting and changing shopping habits, ...
The companies — CVS-owned Caremark Rx, Cigna Group's Express Scripts and UnitedHealth Group's Optum Rx — acted in ways that stifled industry competition for insulin drugs, including by using ...
With CVS ( CVS) reportedly weighing a breakup of its vertical businesses, the healthcare industry could be marching toward ...
Texas Attorney General Ken Paxton alleges several major manufacturers and pharmacy benefit managers have driven the costs of ...
Glenview Capital Management — a hedge fund that has been subject of certain media reports that it was pushing CVS Health ...
The case accuses UnitedHealth Group’s Optum unit, CVS Health’s CVS Caremark and Cigna’s Express Scripts of unfairly excluding lower cost insulin products from lists of drugs covered by insurers.
The Woonsocket, R.I.-based health care giant said it would cut more than 100 positions in January at its corporate office in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback